Doxercalciferol Injection shortage
To Be Discontinued 3 presentations · 1 manufacturers · first FDA posting Dec 10, 2025 · last update Dec 10, 2025
Manufacturers: Sanofi-Aventis U.S. LLC
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Hectorol, Injection, 4 mcg/2 mL injection 50 single-dose vials (NDC 58468-0123-1) | Sanofi-Aventis U.S. LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Dec 10, 2025 Updated Dec 10, 2025 Discontinued Dec 10, 2025 |
| Hectorol, Injection, 2 mcg/mL injection 50 single-dose vials (NDC 58468-0126-1) | Sanofi-Aventis U.S. LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Dec 10, 2025 Updated Dec 10, 2025 Discontinued Dec 10, 2025 |
| Hectorol, Injection, 4 mcg/2 mL injection 50 multiple-dose vials (NDC 58468-0127-1) | Sanofi-Aventis U.S. LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Dec 10, 2025 Updated Dec 10, 2025 Discontinued Dec 10, 2025 |